Supreme Court

Case: 24-0239    
24-0239
03/27/2024
Petition for Writ of Mandamus
IN RE NOVARTIS PHARMACEUTICALS CORPORATION 
 
Appellate Briefs
Date▲▼Event Type▲▼Description▲▼RemarksDocument
12/20/2024Reply BriefRelator Reply Brief on the Merits filed on behalf of Novartis Pharmaceuticals Corporation.
12/19/2024Amicus Curiae Brief receivedReceived (instead of filed) Amicus Curiae Brief received on behalf of Pharmaceutical Research and Manufacturers of America, submitted by Phillip M. Aurentz of Sidley Austin LLP of Dallas, Texas, et al.
11/20/2024Brief on the MeritsReal Parties in Interest Real Party in Interest's Response Brief on the Merits filed on behalf of the State of Texas.
11/20/2024Brief on the MeritsReal Parties in Interest Real Party in Interest's Response Brief on the Merits filed on behalf of Health Selection Group, LLC.
10/29/2024Amicus Curiae Brief receivedReceived (instead of filed) Amicus Brief received on behalf of U.S. Chamber of Commerce.
09/30/2024Brief on the MeritsRelator Relator's Brief on the Merits filed on behalf of Novartis Pharmaceuticals Corporation.
08/02/2024Reply to Petition for Writ of MandamusRelator Reply in Support of Petition for Writ of Mandamus filed on behalf of Novartis Pharmaceuticals Corporation.
07/17/2024Response to Petition for Writ of Mandamus FiledReal Parties in Interest Response to Petition for Writ of Mandamus filed on behalf of the State of Texas.
07/17/2024Response to Petition for Writ of Mandamus FiledReal Parties in Interest Response to Petition for Writ of Mandamus and Motion for Temporary Stay filed on behalf of Health Selection Group, LLC.
03/27/2024Petition for Writ of Mandamus filedRelator Petition for Writ of Mandamus filed on behalf of Novartis Pharmaceuticals Corporation.
Case Events
Date▲▼Event Type▲▼Disposition▲▼RemarksDocument
12/05/2025Case Stored  e-stored
10/24/2025Stay Order lifted  Stay order issued August 30, 2024 is lifted.
10/24/2025Statement Issued  Statement of Justice Young and Justice Sullivan respecting the denial of the petition for writ of mandamus.
10/24/2025Petition for Writ of Mandamus disposedDenied
12/20/2024Reply Brief  Reply Brief on the Merits filed on behalf of Novartis Pharmaceuticals Corporation.
12/19/2024Amicus Curiae Brief received  Amicus Curiae Brief received on behalf of Pharmaceutical Research and Manufacturers of America, submitted by Phillip M. Aurentz of Sidley Austin LLP of Dallas, Texas, et al.
12/19/2024Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Scott D. Stein is granted.
12/19/2024Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Joshua J. Fougere is granted.
12/19/2024Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Kwaku A. Akowuah is granted.
12/19/2024Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Scott D. Stein’s Admission Pro Hac Vice is granted.
12/19/2024Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Joshua J. Fougere’s Admission Pro Hac Vice is granted.
12/19/2024Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Kwaku A. Akowuah’s Admission Pro Hac Vice is granted.
12/19/2024Pro hac vice motion filed  Motion of Resident Attorney in support of Kwaku A. Akowuah's Admission Pro Hac Vice filed on behalf of Pharmaceutical Research and Manufacturers of America.
12/19/2024Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Kwaku A. Akowuah filed on behalf of Pharmaceutical Research and Manufacturers of America.
12/19/2024Pro hac vice motion filed  Motion of Resident Attorney in support of Joshua J. Fougere's Admission Pro Hac Vice filed on behalf of Pharmaceutical Research and Manufacturers of America.
12/19/2024Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Joshua J. Fougere filed on behalf of Pharmaceutical Research and Manufacturers of America.
12/19/2024Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Scott D. Stein filed on behalf of Pharmaceutical Research and Manufacturers of America.
12/19/2024Pro hac vice motion filed  Motion of Resident Attorney in support of Scott D. Stein's Admission Pro Hac Vice filed on behalf of Pharmaceutical Research and Manufacturers of America.
11/26/2024Motion for Extension of Time disposed.Filing granted Motion for Extension of Time to file Reply Brief on the Merits is granted. Reply Brief is due December 20, 2024. FURTHER REQUESTS FOR EXTENSIONS OF TIME FOR THIS FILING WILL BE DISFAVORED.
11/22/2024Motion for Extension of Time to File Brief filed  Unopposed Motion for Extension of Time to file Reply Brief on the Merits filed on behalf of Novartis Pharmaceutical Corporation.
11/20/2024Brief on the Merits  Real Party in Interest's Response Brief on the Merits filed on behalf of the State of Texas.
11/20/2024Case Record Filed   Supplemental Mandamus Record filed on behalf of Health Selection Group, LLC.
11/20/2024Brief on the Merits  Real Party in Interest's Response Brief on the Merits filed on behalf of Health Selection Group, LLC.
10/29/2024Amicus Curiae Brief received  Amicus Brief received on behalf of U.S. Chamber of Commerce.
10/17/2024Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Justin W. Aimonetti's Admission Pro Hac Vice is granted.
10/17/2024Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Michael Scott Proctor's Admission Pro Hac Vice is granted.
10/17/2024Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Michael H. McGinley's Admission Pro Hac Vice is granted.
10/17/2024Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice fo Justin W. Aimonetti is granted.
10/17/2024Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Michael Scott Proctor is granted.
10/17/2024Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Michael H. McGinley is granted.
10/17/2024Pro hac vice motion filed  Motion of Resident Attorney in Support of Justin W. Aimonetti's Admission Pro Hac Vice filed on behalf of  U.S. Chamber of Commerce.
10/17/2024Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Justin W. Aimonetti filed on behalf of U.S. Chamber of Commerce.
10/17/2024Pro hac vice motion filed  Motion of Resident Attorney in Support of Michael Scott Proctor's Admission Pro Hac Vice filed on behalf of  U.S. Chamber of Commerce.
10/17/2024Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Michael Scott Proctor filed on behalf of U.S. Chamber of Commerce.
10/17/2024Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Michael H. McGinley filed on behalf of U.S. Chamber of Commerce.
10/17/2024Pro hac vice motion filed  Motion of Resident Attorney in Support of Michael H. McGinley's Admission Pro Hac Vice filed on behalf of  U.S. Chamber of Commerce.
10/16/2024Call received  Call regarding requirements for pro hac vice status attorneys.
10/16/2024Pro hac vice motion disposedFiling granted Motion for Steven A. Engel's Admission Pro Hac Vice is granted.
10/16/2024Pro hac vice motion disposedFiling granted Motion in support of Steven A. Engel's Admission Pro Hac Vice is granted.
10/15/2024Pro hac vice motion filed  Motion for Steven A. Engel's Admission Pro Hac Vice filed on behalf of U.S. Chamber of Commerce.
10/15/2024Pro hac vice motion filed  Motion in support of Steven A. Engel's Admission Pro Hac Vice filed on behalf of U.S. Chamber of Commerce.
10/11/2024Motion for Extension of Time disposed.Filing granted Motion for Extension of Time to file Real Party in Interest's Brief on the Merits is granted. Real Party in Interest's Brief is due November 20, 2024. Further requests for extensions of time for this filing will be disfavored. Reply Brief is due December 5, 2024.
10/11/2024Motion for Extension of Time to File Brief filed  Motion for Extension of Time to file Real Party in Interest's Brief on the Merits filed on behalf of Health Selection Group, LLC, et al.
10/02/2024Call received  Call regarding requirements for filing amicus brief.
09/30/2024Brief on the Merits  Relator's Brief on the Merits filed on behalf of Novartis Pharmaceuticals Corporation.
09/27/2024Call received  Call received from counsel for Relator regarding merits briefing.
08/30/2024Brief on the Merits Ordered  Brief on the merits requested: Relator's brief due no later than September 30, 2024; Response brief due October 21, 2024; Reply brief due November 5, 2024.
08/30/2024Stay Order issued  Justice Blacklock notes his dissent from the grant of the motion to stay and would deny the motion.
08/30/2024Motion to Stay DisposedFiling granted Relator's Motion for Temporary Stay granted
08/02/2024Reply to Petition for Writ of Mandamus  Reply in Support of Petition for Writ of Mandamus filed on behalf of Novartis Pharmaceuticals Corporation.
07/17/2024Response to Petition for Writ of Mandamus Filed  Response to Petition for Writ of Mandamus and Motion for Temporary Stay filed on behalf of Health Selection Group, LLC.
07/17/2024Response to Petition for Writ of Mandamus Filed  Response to Petition for Writ of Mandamus filed on behalf of the State of Texas.
06/10/2024Additional Copies received  Copy of Motion for Extension of Time to file Response to Petition for Writ of Mandamus filed on behalf of Health Selection Group, LLC.
06/10/2024Motion for Extension of Time to File Response disposedFiling granted Unopposed Motion for Extension of Time to file Response to Petition for Writ of Mandamus is granted. Response is due July 17, 2024. FURTHER REQUESTS FOR EXTENSIONS OF TIME FOR THIS FILING WILL BE DISFAVORED.
06/10/2024Motion for Extension of Time to File Response  Unopposed Motion for Extension of Time to file Response to Petition for Writ of Mandamus filed on behalf of Health Selection Group, LLC.
06/07/2024Notice from Counsel of a change in address  Notice of Change in Address filed on behalf of Novartis Pharmaceuticals Corporation.
06/07/2024Notice from Counsel of a change in address  Notice of Change in Address filed on behalf of Novartis Pharmaceuticals Corporation.
05/28/2024Motion for Extension of Time to File Response disposedFiling granted Unopposed Motion for Extension of Time to file Response to Petition for Writ of Mandamus is granted. Response is due July 17, 2024. FURTHER REQUESTS FOR EXTENSIONS OF TIME FOR THIS FILING WILL BE DISFAVORED.
05/28/2024Motion for Extension of Time to File Response  Unopposed Motion for Extension of Time to file Response to Petition for Writ of Mandamus filed on behalf of the State of Texas.
05/17/2024Supreme Court of Texas Requested Response  Requested response to petition for writ of mandamus due no later than June 17, 2024.
04/29/2024Letter Filed  Letter filed on behalf of Novartis Pharmaceuticals Corporation.
04/16/2024Case forwarded to Court 
04/03/2024Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Anton Metlitsky’s Admission Pro Hac Vice is granted.
04/03/2024Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Anton Metlitsky is granted.
04/03/2024Pro hac vice motion disposedFiling granted Motion of Resident Attorney in Support of Ross B. Galin’s Admission Pro Hac Vice is granted.
04/03/2024Pro hac vice motion disposedFiling granted Motion for Admission Pro Hac Vice for Ross B. Galin is granted.
04/02/2024Pro hac vice motion filed  Motion of Resident Attorney Danny S. Ashby in Support of Anton Metlitsky's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
04/02/2024Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Anton Metlitsky filed on behalf of Novartis Pharmaceuticals Corporation.
04/02/2024Pro hac vice motion filed  Motion of Resident Attorney Danny S. Ashby in Support of Ross B. Galin's Admission Pro Hac Vice filed on behalf of Novartis Pharmaceuticals Corporation.
04/02/2024Pro hac vice motion filed  Motion for Admission Pro Hac Vice for Ross B. Galin filed on behalf of Novartis Pharmaceuticals Corporation.
03/27/2024Case Record Filed   Mandamus Record filed on behalf of Novartis Pharmaceuticals Corporation.
03/27/2024Motion to Stay Filed   Motion for Temporary Stay filed on behalf of Novartis Pharmaceuticals Corporation.
03/27/2024Petition for Writ of Mandamus filed  Petition for Writ of Mandamus filed on behalf of Novartis Pharmaceuticals Corporation.
Calendars
Set Date▲▼Calendar Type▲▼Reason Set▲▼Remarks▲▼
12/05/2025Case StoredCase stored.e-stored
Parties
Party▲▼Party Type▲▼Representative▲▼
U.S. Chamber of CommerceAmicus CuriaeMichael Scott Proctor
Michael H. McGinley
Lindsey Cohan
Justin W. Aimonetti
Steven A. Engel
Novartis Pharmaceuticals CorporationRelatorAnton Metlitsky
Mr. Danny S. Ashby
Ross B. Galin
Mr. Deron R. Dacus
Megan R. Whisler
State of TexasReal Party in Interest Jordan Underhill
Jonathan D. Bonilla
Mr. James Lloyd
Atty. Gen. W. Kenneth Paxton Jr.
Ms. Elizabeth J. Brown Fore
Ms. Cynthia Lu
Ms. Lynne Kurtz-Citrin
Mr. Brent Webster
Ms. Jessica Weltge
Pharmaceutical Research and Manufacturers of America (PhRMA)Amicus CuriaeScott D. Stein
Joshua J. Fougere
Phillip Aurentz
Kwaku A. Akowuah
Health Selection Group, LLCReal Party in Interest Mr. Zeke DeRose III
Mr. W. Mark Lanier
Mr. Kenneth W. Starr
Alex J. Brown
Mr. Samuel F. Baxter
Mr. Chris L. Gadoury
Mr. Jonathan Wilkerson
Ms. Jennifer L. Truelove
Radu A. Lelutiu
Ryan Ellis
Court of Appeals Information:
Denied 
___ SW3d ___, 03-01-24 
6th Court of Appeals 
Honorable Scott E. Stevens 
Trial Court Information
71st District Court 
Harrison 
Honorable Brad Morin 
23-0276